Bulgaria – Medical consumables – Periodically recurring supplies of dressing and suture materials, medical consumables for sterilization, and incise drapes for the surgical field

Opportunity description

The subject of the public procurement includes the selection of a contractor for periodically recurring supplies of dressing and suture materials, medical consumables for sterilization, and incise drapes for the surgical field, as follows: 1. Gauze swabs, bandages, adhesive dressings 2. Sterile dressings and specific wound dressings 3. Dressing material 4. Sterile absorbable local haemostat to support haemostasis in capillary and venous bleeding, gelatin-based or made of another biocompatible material with an equivalent mechanism and profile of action, in sponge or powder form according to the sub-item; ready for use and in individual sterile packaging. 5. Sterile absorbable cellulose local haemostat in gauze form 6. Sterile absorbable cellulose local haemostat in wadding form 7. Sterile absorbable cellulose local haemostat in powder form 8. Sterile absorbable cellulose local haemostat in gel form 9. Surgical needles 10. Sterile bone wax or another biocompatible mouldable material with an equivalent intended purpose for mechanical haemostasis of bone surfaces; net weight 2.5 g with a permissible deviation of ±5%; individual sterile packaging. 11. Sterile disposable skin stapler with no fewer than 35 staples made of biocompatible metal; wire diameter 0.45–0.55 mm; formed staple dimensions: width 6.5–8.0 mm and height 4.4–5.4 mm; ergonomic one-handed activation and visual monitoring of the remaining staples or an equivalent mechanism. 12. Sterile coloured non-absorbable monofilament surgical suture made of PVDF or another biocompatible synthetic material with equivalent permanent strength, low tissue reactivity and intended purpose; individual sterile packaging and an atraumatic needle made of corrosion-resistant medical material. 13. Sterile non-absorbable synthetic surgical suture without needle, on a spool, made of polyamide or another biocompatible material with equivalent permanent strength; monofilament or treated multifilament with a smooth surface and low capillarity 14. Sterile synthetic non-absorbable braided surgical suture made of polyester or another biocompatible material with equivalent permanent strength, with biocompatible treatment for reduced friction and a stable knot 15. Sterile non-absorbable braided surgical suture made of natural silk or another biocompatible material with equivalent intended purpose and knot security, with biocompatible treatment to reduce friction and capillarity 16. Sterile synthetic absorbable monofilament surgical suture with short-term tissue support: residual strength 20–70% on day 7 and complete absorption within 90–130 days; made of glycolide/caprolactone copolymer or another biocompatible material with an equivalent profile. Configuration with a taper-point needle. 17 Sterile synthetic absorbable monofilament surgical suture with short-term tissue support: residual strength 20–70% on day 7 and complete absorption within 90–130 days; made of glycolide/caprolactone copolymer or another biocompatible material with an equivalent profile. Configuration with a cutting needle. 18. Sterile synthetic slowly absorbable monofilament surgical suture with residual strength of 40–70% on day 42 and complete absorption in 180–240 days; made of polydioxanone or another biocompatible material with an equivalent clinical profile. 19. Sterile synthetic slowly absorbable monofilament surgical suture with residual strength of 40–70% on day 42 and complete absorption in 180–240 days; made of polydioxanone or another biocompatible material with an equivalent clinical profile. Implemented as a knotless barbed system with evenly distributed fixation elements and a functional end stopper/loop 20. Sterile absorbable knotless soft-tissue closure system, comprising a monofilament barbed suture and a functional end-fixation mechanism that permits closure without a surgical knot; complete absorption in 90–130 days 21. Sterile synthetic absorbable braided surgical suture with medium-term tissue support, residual strength of no less than 80% on day 14 and no less than 50% on day 21, and complete absorption in 56–120 days; made of PGA or another biocompatible material with an equivalent profile; with biocompatible treatment to reduce friction. Configured with a taper-point needle 22. Sterile synthetic absorbable braided surgical suture with medium-term tissue support, residual strength of no less than 80% on day 14 and no less than 50% on day 21, and complete absorption in 56–120 days; made of PGA or another biocompatible material with an equivalent profile; with biocompatible treatment to reduce friction. Loop-type configuration 23. Sterile synthetic absorbable braided surgical suture with medium-term tissue support, residual strength of no less than 80% on day 14 and no less than 50% on day 21, and complete absorption in 56–120 days in the form of ligatures 24. Sterile synthetic braided surgical suture, with medium absorption and residual strength of 25–65% on day 7 and complete absorption in 40–70 days; made of PGA or another biocompatible material with an equivalent clinical profile; with treatment to reduce friction. 25. Sterile synthetic rapidly absorbable braided surgical suture with residual strength of 30–70% on day 7 and approximately 0% on day 14; made of PGA biocompatible material with an equivalent clinical profile; with treatment to reduce friction. 26. Sterile soft elastic surgical tape/loop made of medical silicone or another biocompatible elastomer with equivalent flexibility and intended purpose, colour-coded for visual differentiation 27. Medical consumables for sterilization 28. Incise drapes for the surgical field, various sizes. The examination and evaluation of the submitted tenders, in accordance with the selected award criterion, shall be carried out by the Committee pursuant to Art. 61 of the Rules for the Implementation of the Public Procurement Act, with participants’ technical and price proposals evaluated before examination of the documents establishing compliance with the selection criteria. The subject of the lot includes the selection of a contractor for periodically recurring supplies of gauze swabs, bandages and adhesive dressings, as follows: 1.1 Non-sterile gauze swabs without X-ray detectable thread /package of 100 pcs., 5 cm × 5 cm, 8-ply, packages 5000 1.2 Non-sterile gauze swabs without X-ray detectable thread /package of 100 pcs., 10 cm × 10 cm, 8-ply, packages 5000 1.3 Laparotomy swabs without X-ray detectable thread – 50 cm × 50 cm, 8-ply, 15 threads, minimum weight 21 g per m2, units 15000 1.4 Absorbent gauze on a roll, metres 2000 1.5 Gauze bandages 1.5.1 10 m × 10 cm, 17 threads, units 10000 1.5.2 10 m × 5 cm, 17 threads, units 500 1.6 Hypoallergenic self-adhesive tape made of soft non-woven polyester fibres 1.6.1 5 cm × 10 m, units 500 1.6.2 10 cm × 10 m, units 1000 1.7 Hypoallergenic silk adhesive plaster 1.7.1 2.5 cm × 5 m, units 4000 1.7.2 5 cm × 5 m, units 4000 1.8 Cytoplast, size 6 cm × 1 m, units 50 1.9 Sterile hypoallergenic adhesive dressing for fixation of an intravenous cannula, with a non-adherent absorbent pad. It keeps the puncture site dry and prevents the pad from adhering to the puncture site. The dressing contains hypoallergenic acrylic adhesive, a slit for wrapping around the tube and an additional cushioning pad – transparent, 8 cm × 6 cm, units 2000 1.10 Dressing for a peripheral IV catheter integrating a transparent hydrogel impregnated with chlorhexidine gluconate /CHG/, intended to cover and protect catheter insertion sites and secure devices to the skin. Impermeable to water, bacteria and viruses, breathable, in three sizes: 7 × 8.5 cm, 8.5 × 11.5 cm, 10 × 12 cm, units 100. The subject of the lot includes the selection of a contractor for periodically recurring supplies of sterile dressings and specific wound dressings, as follows: 2.1 Sterile highly absorbent self-fixing dressing with a core of superabsorbent particles and a contact silicone layer providing immediate adhesion; with an adhesive border; with a top layer of waterproof film permitting bathing 2.1.1 12.5 × 12.5 cm, with absorbent pad 10.5 × 10.5 cm, units 50 2.1.2 10 × 20 cm, with absorbent pad 8 × 18 cm, units 200 2.1.3 20 × 20 cm, with absorbent pad 18 × 18 cm, units 200 2.1.4 20 × 25 cm, with absorbent pad 18 × 23 cm, units 50 2.2 Sterile tulle ointment dressing with antibacterial effect, impregnated with metallic silver and a mixture of esters of natural fatty acids and glycerol of plant origin 2.2.1 10 × 10 cm, packages 60 2.2.2 10 × 20 cm, packages 20 2.3 Highly absorbent self-fixing hydroactive polyurethane dressing with an open-pore capillary-action system for moderately to heavily exuding ulcers 2.3.1 size 10 × 10 cm, non-adhesive area 5 × 5 cm, units 200 2.3.2 size 15 × 15 cm, non-adhesive area 10 × 10 cm, units 200 2.3.3 size 30 × 10 cm, non-adhesive area 24 × 5 cm, units 200 2.4 Highly absorbent self-fixing hydroactive polyurethane dressing with an open-pore capillary-action system for moderately to heavily exuding ulcers, with a water-vapour-permeable top layer; for the sacral area 2.4.1 size 18 × 18 cm, non-adhesive area 11 × 9.5 cm, units 100 2.4.2 size 22.5 × 22.5 cm, non-adhesive area 13.5 × 11.5 cm, units 100 2.5 Sterile self-fixing dressing with rounded edges, made of soft non-woven material, with a two-layer pad of the size stated on the package, comprising a permeable polyethylene mesh contact layer that does not adhere to the wound and an absorbent viscose layer; with hypoallergenic synthetic adhesive free of rosin, latex and phthalates; with a measuring scale on the packaging and an application system with fingerlift and transversely peelable backing paper 2.5.1 35 cm × 10 cm, with pad 30.5 × 5.5 cm, units 10000 2.5.2 25 cm × 10 cm, with pad 20.5 × 5.5 cm, units 10000 2.5.3 15 × 6 cm, pad 11 × 2.5 cm, units 10000 2.5.4 7.2 × 5 cm, pad 4 × 2.5 cm, units 10000 2.5.5 10 × 8 cm, pad 6.5 × 3.8 cm, units 20000 2.6 Transparent self-fixing dressing with an absorbent pad covered by a water- and bacteria-impermeable polyethylene film, with rounded edges and a fingerlift application system indicating 4 steps. 2.6.1 5 × 7.2 cm, absorbent pad – 2.5 × 4 cm, units 1000 2.6.2 9 × 10 cm, absorbent pad – 4 × 6 cm, units 1000 2.6.3 10 × 20 cm, absorbent pad – 5 × 16 cm, units 1000 2.6.4 10 × 25 cm, absorbent pad – 5 × 20 cm, units 1000 2.6.5 10 × 30 cm, absorbent pad – 5 × 25 cm, units 500 2.7 Cohesive bandage with a crepe structure and special latex-free coating, composed of 43% viscose, 37% cotton and 20% polyamide, 85% extensibility; adheres only to itself, not to skin, hair or clothing; plain weave; in individual cardboard packaging, dimensions: 2.7.1 6 cm/4 m, units 50 2.7.2 10 cm/4 m, units 50 2.7.3 10 cm/20 m, units 50 2.8 Hypoallergenic self-adhesive tape made of soft non-woven polyester fibres for attaching and securing dressings, latex-free, elastic across its width, with wave-cut backing paper, with high air and moisture permeability, dimensions: 2.8.1 5 cm × 10 m, units 100 2.8.2 10 cm × 10 m, units 2000 2.8.3 15 cm × 10 m, units 50 2.8.4 20 cm × 10 m, units 50 2.9 Hypoallergenic self-adhesive tape made of artificial silk with 100% acetate fibres, synthetic rosin-free adhesive, easy to tear, removed painlessly without residue 2.9.1 9.2 m × 5 cm, units 50 2.9.2 5 m × 5 cm, units 500 2.9.3 9.2 m × 2.5 cm, units 50 2.10 Sterile hypoallergenic strips made of non-woven polyester with rounded edges, with transverse elasticity of 75% and longitudinal elasticity of 32% 2.10.1 25 × 127 mm, packages 20 2.10.2 12 × 101 mm, packages 20 2.10.3 6 × 76 mm, packages 80 2.10.4 3 × 76 mm, packages 20 2.11 Sterile self-fixing dressing for central venous lines/cannulas, made of non-woven material, with a transparent-film window for monitoring and a slit, with three additional fixation strips, oval shape, size 10 × 12 cm, units 1000 2.12 Sterile pad-type atraumatic dressing – compress, with a core of highly absorbent defibrated cellulose 2.12.1 10 cm × 20 cm, units 20000 2.12.2 15 cm × 25 cm, units 15000 2.12.3 10 cm × 10 cm, units 15000 2.13 Fixation silicone tape made of non-woven material coated with an atraumatic silicone layer, with wave-cut protective film and directional arrows, size 10 cm × 5 m, units 20 2.14 Sterile self-fixing dressing with a slit for cannulas, rounded edges, made of non-woven textile, with a two-layer pad: a permeable polyethylene mesh contact layer that does not adhere to the wound and an absorbent viscose layer; additional cleansing swab; size 8 × 6 cm, units 20000 2.15 Colourless waterproof spray dressing that forms an invisible film to protect against bacteria and contaminants and protects against friction, units 50. The subject of the lot includes the selection of a contractor for periodically recurring supplies of dressing material, as follows: 3.1 Sanplast 3.1.1 2.5 cm × 5 m, units 1000 3.1.2 5 cm × 5 m, units 2000 3.2 Cotton wool, 100% natural white fibres, free of acidic impurities and artificial bleaching agents 3.2.1 package 100 g, units 300 3.2.2 package 1000 g, units 300 3.3 Non-sterile gauze swabs without X-ray detectable thread /package of 100 pcs., 5 cm × 5 cm, 16-ply, packages 4000 3.4 Non-sterile gauze swabs without X-ray detectable thread /package of 100 pcs., 10 cm × 10 cm, 16-ply, packages 8000 3.5 Non-sterile gauze swabs without X-ray detectable thread /package of 100 pcs., 8-ply 3.5.1 5 × 5 cm, packages 5000 3.5.2 7.5 × 7.5 cm, packages 1000 3.5.3 10 × 10 cm, packages 5000 3.6 Gauze swabs for the specific needs of high-risk departments, non-sterile, 100 pcs./package, size 10 cm/10 cm, 16-ply, 17 threads, dyed blue, packages 500 3.7 Gauze swabs for the specific needs of high-risk departments, non-sterile, 100 pcs./package, size 10 cm/10 cm, 8-ply, 17 threads, dyed green, packages 500 3.8 Laparotomy swabs with X-ray detectable thread – 50 cm × 50 cm, 8-ply, 15 threads, minimum weight 21 g per m2, units 40000 3.9 White lignin, 5 kg bale, kg 2000 3.10 Gauze strip with radiopaque PVC chip and additional 27 cm gripping loop, 4-ply, non-sterile, prewashed, size 90 × 8 cm, in bands of 5 pcs., units 2000 3.11 Radiopaque swabs made of twisted highly absorbent cotton gauze, 20 threads/cm2, longitudinal threads 80/10 cm, transverse threads 120/10 cm, minimum 27 g/m2, non-sterile, with an incorporated radiopaque polypropylene thread containing min. 60% BaSO4, for haemostasis and wound treatment 3.11.1 size 2 (walnut), 1000 pcs./package, units 5000 3.11.2 size 3 (plum), 1000 pcs./package, units 5000 3.11.3 size 4 (egg), 1000 pcs./package, units 5000 3.11.4 size 5 (XL), 1000 pcs./package, units 5000 3.12 Radiopaque swabs made of cotton gauze, 24 threads/cm2, non-sterile, radiopaque polypropylene thread, for exposure of organs and tissue during operations. 3.12.1 size S, 1000 pcs./package, units 5000 3.12.2 size M, 1000 pcs./package, units 5000 3.12.3 size L, 1000 pcs./package, units 5000 3.13 Cap impregnated with shampoo and conditioner for no-rinse washing. Contains Aloe vera extract, panthenol and lactic acid. Balanced pH, value – 5.0–6.0. Free of alcohol and sulphates, units 100. The subject of the lot includes the selection of a contractor for periodically recurring supplies of a sterile absorbable local haemostat to support haemostasis in capillary and venous bleeding, gelatin-based or made of another biocompatible material with an equivalent mechanism and profile of action, in sponge or powder form according to the sub-item; ready for use and in individual sterile packaging, as follows: 4.1 Sterile absorbable local haemostat to support haemostasis in capillary and venous bleeding, gelatin-based or made of another biocompatible material with an equivalent mechanism and profile of action, in sponge form with dimensions according to the sub-item, ready for use and in individual sterile packaging. 4.1.1 Sterile absorbable local haemostat in sponge form, gelatin-based or made of another biocompatible material with an equivalent profile of action; nominal size 80 × 50 × 1 mm, with a permissible deviation of ±15% for each dimension; individual sterile packaging, units 2500 4.1.2 Sterile absorbable local haemostat in sponge form, gelatin-based or made of another biocompatible material with an equivalent profile of action; nominal size 80 × 50 × 10 mm, with a permissible deviation of ±15% for each dimension; individual sterile packaging, units 3500 4.1.3 Sterile absorbable local haemostat in cylindrical sponge form, gelatin-based or made of another biocompatible material with an equivalent profile of action; nominal size 80 × 30 mm, with a permissible deviation of ±5% for each dimension; individual sterile packaging, units 1000 4.1.4 Sterile absorbable local haemostat in sponge form, gelatin-based or made of another biocompatible material with an equivalent profile of action; nominal size 10 × 10 × 10 mm, with a permissible deviation of ±5% for each dimension; individual sterile packaging, units 600 4.2 Sterile absorbable local haemostat in powder form, gelatin-based or made of another biocompatible material with an equivalent profile of action; net weight no less than 1 g; ready for local application; individual sterile packaging, units 500. The subject of the lot includes the selection of a contractor for periodically recurring supplies of a sterile absorbable cellulose local haemostat in gauze form, as follows: 5.1 Sterile absorbable local haemostat in the form of dense cellulose fabric/mesh (gauze) or an equivalent biocompatible structure, suitable for controlling diffuse bleeding, which can be cut and adapted to the wound; nominal size 50 × 75 mm, tolerance ±5%; individual sterile packaging, units 900 5.2 Sterile absorbable local haemostat in the form of dense cellulose fabric/mesh (gauze) or an equivalent biocompatible structure, suitable for controlling diffuse bleeding, which can be cut and adapted to the wound; nominal size 100 × 100 mm, tolerance ±5%; individual sterile packaging, units 300. The subject of the lot includes the selection of a contractor for periodically recurring supplies of a sterile absorbable cellulose local haemostat in wadding form, as follows: 6.1 Sterile absorbable cellulose local haemostat in fibrous/multilayer form (wadding), suitable for controlled placement in capillary and venous bleeding; onset of haemostatic action within 5 min; complete absorption within 21 days; nominal size 50 × 100 mm, tolerance ±5%; individual sterile packaging, units 500 6.2 Sterile absorbable cellulose local haemostat in fibrous/multilayer form (wadding), suitable for controlled placement in capillary and venous bleeding; onset of haemostatic action within 5 min; complete absorption within 21 days; nominal size 100 × 100 mm, tolerance ±5%; individual sterile packaging, units 400. The subject of the lot includes the selection of a contractor for periodically recurring supplies of a sterile absorbable cellulose local haemostat in powder form, as follows: 7.1 Sterile absorbable haemostatic powder for controlled application in difficult-to-access areas, with a compatible applicator included; net weight no less than 2 g; ready for use; material and mechanism proven to be biocompatible and suitable for the intended purpose; individual sterile packaging, units 200. The subject of the lot includes the selection of a contractor for periodically recurring supplies of a sterile absorbable cellulose local haemostat in gel form, as follows: 8.1 Sterile absorbable local haemostat in the form of a ready-to-use gel or equivalent viscous form, volume no less than 3 ml, supplied as a prefilled syringe or equivalent ready-to-use application system; compatible with standard laparoscopic access; biocompatibility, intended purpose and absorption profile shall be demonstrated by the Instructions for Use, units 60 8.2 Sterile absorbable local haemostat in the form of a ready-to-use gel or equivalent viscous form, volume no less than 6 ml, supplied as a prefilled syringe or equivalent ready-to-use application system; compatible with standard laparoscopic access; biocompatibility, intended purpose and absorption profile shall be demonstrated by the Instructions for Use, units 60. The subject of the lot includes the selection of a contractor for periodically recurring supplies of surgical needles, as follows: 9.1 Sterile surgical needle for manual placement of intestinal sutures, made of corrosion-resistant medical material; length 70 mm; diameter 1.3 mm; 1/2-circle shape, units 120 9.2 Sterile surgical needle for manual placement of intestinal sutures, made of corrosion-resistant medical material; length 65 mm; diameter 1.3 mm; 1/2-circle shape, units 120 9.3 Sterile surgical needle for manual placement of intestinal sutures, made of corrosion-resistant medical material; length 60 mm; diameter 1.2 mm; 1/2-circle shape, units 120 9.4 Sterile surgical cutting needle for manual placement of sutures, made of corrosion-resistant medical material; length 65 mm; diameter 0.65–1.4 mm; 3/8-circle shape, units 288 9.5 Same specification, length 60 mm, units 288 9.6 Same specification, length 55 mm, units 288 9.7 Same specification, length 50 mm, units 288 9.8 Same specification, length 45 mm, units 288 9.9 Same specification, length 40 mm, units 288 9.10 Same specification, length 35 mm, units 288 9.11 Same specification, length 32 mm, units 288 9.12 Same specification, length 30 mm, units 288 9.13 Same specification, length 28 mm, units 288 9.14 Same specification, length 25 mm, units 288 9.15 Sterile fascial surgical needle made of corrosion-resistant medical material; thickness 1–2 mm and length 90 mm; 1/2-circle shape, units 264 9.16 Same specification, length 85 mm, units 264 9.17 Same specification, length 80 mm, units 264 9.18 Same specification, length 75 mm, units 264 9.19 Same specification, length 70 mm, units 264 9.20 Same specification, length 65 mm, units 264 9.21 Same specification, length 60 mm, units 264 9.22 Same specification, length 55 mm, units 264 9.23 Same specification, length 50 mm, units 264 9.24 Sterile Bassini-type surgical needle or equivalent in intended purpose for placement of deep-tissue sutures, made of corrosion-resistant medical material; diameter 1–1.5 mm; length 50 mm, units 96 9.25 Same specification, length 45 mm, units 96 9.26 Same specification, length 40 mm, units 96 9.27 Same specification, length 35 mm, units 96. The subject of the lot includes the selection of a contractor for periodically recurring supplies of sterile bone wax or another biocompatible mouldable material with an equivalent intended purpose for mechanical haemostasis of bone surfaces; net weight 2.5 g with a permissible deviation of ±5%; individual sterile packaging, units 120. The subject of the lot includes the selection of a contractor for periodically recurring supplies of a sterile disposable skin stapler with no fewer than 35 staples made of biocompatible metal; wire diameter 0.45–0.55 mm; formed staple dimensions: width 6.5–8.0 mm and height 4.4–5.4 mm; ergonomic one-handed activation and visual monitoring of the remaining staples or an equivalent mechanism, units 600. The subject of the lot includes the selection of a contractor for periodically recurring supplies of sterile coloured non-absorbable monofilament surgical suture made of PVDF or another biocompatible synthetic material with equivalent permanent strength, low tissue reactivity and intended purpose; individual sterile packaging and an atraumatic needle made of corrosion-resistant medical material, as follows: 12.1 Configuration: 22 mm, 1/2 circle, taper-point needle, 2/0, length 75 cm, units 288 12.2 Configuration: 22 mm, 1/2 circle, taper-point needle, 2 needles, 2/0, length 90 cm, units 288 12.3 Configuration: 26 mm, 1/2 circle, taper-point needle, 2/0, length 75 cm, units 288 12.4 Configuration: 22 mm, 1/2 circle, taper-point needle, 3/0, length 75 cm, units 288 12.5 Configuration: 22 mm, 1/2 circle, taper-point needle with increased bending resistance declared by the manufacturer, 2 needles, 3/0, length 90 cm, units 288 12.6 Configuration: 26 mm, 1/2 circle, taper-point needle, 3/0, length 75 cm, units 288 12.7 Configuration: 26 mm, 1/2 circle, taper-point needle, 2 needles, 3/0, length 90 cm, units 288 12.8 Configuration: 30 mm, 1/2 circle, taper-point needle, 3/0, length 75 cm, units 288 12.9 Configuration: 30 mm, 1/2 circle, taper-point needle, 2 needles, 3/0, length 90 cm, units 288. For items 12.1–12.9, the stated needle length is nominal with a permissible deviation of ±5%; the stated suture length is the minimum; individual sterile packaging. The subject of the lot includes the selection of a contractor for periodically recurring supplies of sterile non-absorbable synthetic surgical suture without needle, on a spool, made of polyamide or another biocompatible material with equivalent permanent strength; monofilament or treated multifilament with a smooth surface and low capillarity, as follows: 13.1 size 3/0, length 250 cm, units 700 13.2 size 2/0, length 250 cm, units 700 13.3 size 1, length 250 cm, units 700 13.4 size 2, length 250 cm, units 700 13.5 size 3, length 250 cm, units 700 13.6 size 5, length 250 cm, units 700. For items 13.1–13.6: without needle (on a spool); individual sterile packaging; the length is the minimum. The subject of the lot includes the selection of a contractor for periodically recurring supplies of sterile synthetic non-absorbable braided surgical suture made of polyester or another biocompatible material with equivalent permanent strength, with biocompatible treatment for reduced friction and a stable knot; atraumatic needle made of corrosion-resistant medical material with suitable surface treatment, as follows: 14.1 USP 0; 1/2 circle, taper-point needle, 30 mm; suture length 75 cm, units 360 14.2 USP 0; 1/2 circle, taper-point needle, 37 mm; suture length 75 cm, units 360 14.3 USP 1; 1/2 circle, taper-point needle, 30 mm; suture length 75 cm, units 360 14.4 USP 1; 1/2 circle, taper-point needle, 37 mm; suture length 75 cm, units 360 14.5 USP 1; 1/2 circle, taper-point needle, 40 mm; suture length 75 cm, units 360 14.6 USP 2; 1/2 circle, taper-point needle, 37 mm; suture length 75 cm, units 360 14.7 USP 2; 1/2 circle, taper-point needle, 40 mm; suture length 90 cm, units 360 14.8 USP 2; 1/2 circle, taper-point needle, 48 mm; suture length 75 cm, units 360. For items 14.1–14.8, the stated needle length is nominal with a permissible deviation of ±5%; the stated suture length is the minimum; individual sterile packaging. The subject of the lot includes the selection of a contractor for periodically recurring supplies of sterile non-absorbable braided surgical suture made of natural silk or another biocompatible material with equivalent intended purpose and knot security, with biocompatible treatment to reduce friction and capillarity, as follows: 15.1 USP 0; needle nominal length 37 mm, 3/8 circle, cutting needle; suture length 70 cm, units 2000 15.2 USP 1; needle nominal length 37 mm, 3/8 circle, cutting needle; suture length 70 cm, units 2000 15.3 USP 3/0; needle nominal length 24 mm, 3/8 circle, cutting needle; suture length 70 cm, units 1000 15.4 USP 2/0; needle nominal length 24 mm, 3/8 circle, cutting needle; suture length 70 cm, units 1000 15.5 USP 2/0; needle nominal length 30 mm, 1/2 circle, taper-point needle; suture length 45 cm, units 1000 15.6 USP 2/0; needle nominal length 26 mm, 1/2 circle, taper-point needle; suture length 45 cm, units 1000 15.7 without needle, size 3/0, length 10 × 45 cm; the stated length is the minimum; size according to USP/EP or equivalent system, units 1400 15.8 without needle, size 2/0, length 10 × 45 cm; the stated length is the minimum; size according to USP/EP or equivalent system, units 1400. For items 15.1–15.6, the stated needle length is nominal with a permissible deviation of ±5%; the stated suture length is the minimum; individual sterile packaging. The subject of the lot includes the selection of a contractor for periodically recurring supplies of sterile synthetic absorbable monofilament surgical suture with short-term tissue support: residual strength 20–70% on day 7 and complete absorption within 90–130 days; made of glycolide/caprolactone copolymer or another biocompatible material with an equivalent profile. Configuration with a taper-point needle, as follows: 16.1 17 mm, 1/2 circle, taper-point needle, 6/0, length 70 cm, units 240 16.2 22 mm, 1/2 circle, taper-point needle, 5/0, length 70 cm, units 240 16.3 26 mm, 1/2 circle, taper-point needle, 4/0, length 70 cm, units 240 16.4 30 mm, 1/2 circle, taper-point needle, 3/0, length 70 cm, units 240 16.5 30 mm, 1/2 circle, taper-point needle, 2/0, length 70 cm, units 240 16.6 36 mm, 1/2 circle, taper-point needle, 2/0, length 70 cm, units 240 16.7 36 mm, 1/2 circle, taper-point needle, 3/0, length 70 cm, units 240 16.8 36 mm, 1/2 circle, taper-point needle, 0, length 70 cm, units 240 16.9 36 mm, 1/2 circle, taper-point needle with increased bending resistance declared by the manufacturer, 1, length 70 cm, units 240. For items 16.1–16.9: coloured in a contrasting biocompatible colour; the stated needle length is nominal with a permissible deviation of ±5%; the stated suture length is the minimum; individual sterile packaging. The subject of the lot includes the selection of a contractor for periodically recurring supplies of sterile synthetic absorbable monofilament surgical suture with short-term tissue support: residual strength 20–70% on day 7 and complete absorption within 90–130 days; made of glycolide/caprolactone copolymer or another biocompatible material with an equivalent profile. Configuration with a cutting needle, as follows: 17.1 Sterile synthetic absorbable monofilament surgical suture with residual strength 30–70% on day 7 and complete absorption in 90–130 days; made of glycolide/caprolactone copolymer or another biocompatible material with an equivalent clinical profile. Configuration: 18, 7 mm, 3/8 circle, cutting needle, 4/0; length 45 cm, units 374 17.2 Same specification; configuration: 18, 7 mm, 3/8 circle, cutting needle, 4/0; length 70 cm, units 374 17.3 Same specification; configuration: 24, 3 mm, 3/8 circle, cutting needle, 3/0; length 70 cm, units 374. For items 17.1–17.3, the stated needle length is nominal with a permissible deviation of ±5%; the stated suture length is the minimum; individual sterile packaging. The subject of the lot includes the selection of a contractor for periodically recurring supplies of sterile synthetic slowly absorbable monofilament surgical suture with residual strength of 40–70% on day 42 and complete absorption in 180–240 days; made of polydioxanone or another biocompatible material with an equivalent clinical profile, as follows: 18.1 Configuration: 48 mm, 1/2 circle, taper-point needle with increased bending resistance declared by the manufacturer, 1, 150 cm Loop, coloured in a contrasting biocompatible colour; the stated needle length is nominal with a permissible deviation of ±5%; the stated suture length is the minimum; individual sterile packaging, units 800 18.2 Configuration: 65 mm, 1/2 circle, taper-point needle with increased bending resistance declared by the manufacturer, 1, 240 cm Loop, coloured in a contrasting biocompatible colour; the stated needle length is nominal with a permissible deviation of ±5%; the stated suture length is the minimum; individual sterile packaging, units 800 18.3 Sterile synthetic slowly absorbable loop-type monofilament surgical suture, with residual strength of 55–80% on day 28 and 35–70% on day 42 and complete absorption in 180–240 days; made of polydioxanone or another biocompatible material with an equivalent clinical profile. Configuration: 1/2 circle, taper-point needle, 50 mm with increased bending resistance declared by the manufacturer; loop, 2, length 150 cm; the stated needle length is nominal with a permissible deviation of ±5%; the stated suture length is the minimum; individual sterile packaging, units 360 18.4 Same specification; loop, 2, length 240 cm, units 360. The subject of the lot includes the selection of a contractor for periodically recurring supplies of sterile synthetic slowly absorbable monofilament surgical suture with residual strength of 40–70% on day 42 and complete absorption in 180–240 days; made of polydioxanone or another biocompatible material with an equivalent clinical profile. Implemented as a knotless barbed system with evenly distributed fixation elements and a functional end stopper/loop; the intended purpose for knotless closure shall be demonstrated by the Instructions for Use, as follows: 19.1 26 mm, 1/2 circle, taper-point needle, 3/0, length 23 cm, units 120 19.2 26 mm, 1/2 circle, taper-point needle, 2/0, length 23 cm, units 120 19.3 36 mm, 1/2 circle, taper-point needle with increased bending resistance declared by the manufacturer, 3/0, length 23 cm, units 120 19.4 36 mm, 1/2 circle, taper-point needle with increased bending resistance declared by the manufacturer, 2/0, length 23 cm, units 120 19.5 36 mm, 1/2 circle, taper-point needle with increased bending resistance declared by the manufacturer, 0, length 23 cm, units 120 19.6 36 mm, 1/2 circle, taper-point needle with increased bending resistance declared by the manufacturer, 1, length 23 cm, units 120. For items 19.1–19.6: coloured in a contrasting biocompatible colour; the stated needle length is nominal with a permissible deviation of ±5%; the stated suture length is the minimum; individual sterile packaging. The subject of the lot includes the selection of a contractor for periodically recurring supplies of a sterile absorbable knotless soft-tissue closure system, comprising a monofilament barbed suture and a functional end-fixation mechanism that permits closure without a surgical knot; complete absorption in 90–130 days; material and geometry proven by the manufacturer as suitable for the stated intended purpose, as follows: 20.1 USP 0; 1 needle, 1/2 circle, nominal length 26 mm (tolerance ±5%); working length of the barbed suture no less than 23 cm; individual sterile packaging, units 144 20.2 USP 1; 1 needle, 1/2 circle, nominal length 26 mm (tolerance ±5%); working length no less than 23 cm; units 144 20.3 USP 2/0; 1 needle, 1/2 circle, nominal length 26 mm (tolerance ±5%); working length no less than 20 cm; units 144 20.4 USP 2/0; 1 needle, 1/2 circle, nominal length 30 mm (tolerance ±5%); working length no less than 20 cm; units 144 20.5 USP 3/0; 1 needle, 1/2 circle, nominal length 26 mm (tolerance ±5%); working length no less than 20 cm; units 144 20.6 USP 3/0; 1 needle, 1/2 circle, nominal length 30 mm (tolerance ±5%); working length no less than 20 cm; units 144. All items in individual sterile packaging. The subject of the lot includes the selection of a contractor for periodically recurring supplies of sterile synthetic absorbable braided surgical suture with medium-term tissue support, residual strength of no less than 80% on day 14 and no less than 50% on day 21, and complete absorption in 56–120 days; made of PGA or another biocompatible material with an equivalent profile; with biocompatible treatment to reduce friction. Configured with a taper-point needle, as follows: 21.1 26 mm, 1/2 circle, taper-point needle, 3/0, length 70 cm, units 2000 21.2 26 mm, 1/2 circle, taper-point needle, 2/0, length 70 cm, units 2000 21.3 30 mm, 1/2 circle, taper-point needle, 2/0, length 70 cm, units 6000 21.4 30 mm, 1/2 circle, taper-point needle, 3/0, length 70 cm, units 6000 21.5 30 mm, 1/2 circle, taper-point needle, 0, length 70 cm, units 600. For items 21.1–21.5: coloured in a contrasting biocompatible colour; the stated needle length is nominal with a permissible deviation of ±5%; the stated suture length is the minimum; individual sterile packaging. The subject of the lot includes the selection of a contractor for periodically recurring supplies of the same suture in a Loop-type configuration, as follows: 22.1 40 mm, 1/2 circle, taper-point needle with increased bending resistance declared by the manufacturer, 1, length 150 cm, Loop, units 288 22.2 48 mm, 1/2 circle, taper-point needle with increased bending resistance declared by the manufacturer, 1, length 240 cm, Loop, units 288 22.3 48 mm, 1/2 circle, taper-point needle with increased bending resistance declared by the manufacturer, 1, length 150 cm, Loop, units 288 22.4 48 mm, 1/2 circle, taper-point needle with increased bending resistance declared by the manufacturer, 2, length 150 cm, Loop, units 288. For items 22.1–22.4: coloured in a contrasting biocompatible colour; the stated needle length is nominal with a permissible deviation of ±5%; the stated suture length is the minimum; individual sterile packaging. The subject of the lot includes the selection of a contractor for periodically recurring supplies of sterile synthetic absorbable braided surgical suture with medium-term tissue support, residual strength of no less than 80% on day 14 and no less than 50% on day 21, and complete absorption in 56–120 days, in the form of ligatures, as follows: 23.1 3/0, 6 × 45 cm, ligature, units 1728 23.2 2/0, 6 × 45 cm, ligature, units 1728 23.3 1, 6 × 45 cm, ligature, units 1728 23.4 2, 6 × 45 cm, ligature, units 1728 23.5 0, 6 × 45 cm, ligature, units 1728 23.6 3/0, 6 × 70 cm, ligature, units 1728 23.7 2/0, 6 × 70 cm, ligature, units 1728 23.8 0, 6 × 70 cm, ligature, units 1728 23.9 1, 6 × 70 cm, ligature, units 1728 23.10 2, 6 × 70 cm, ligature, units 1728. For items 23.1–23.10: made of PGA or another biocompatible material with an equivalent profile; with biocompatible treatment to reduce friction; coloured in a contrasting biocompatible colour; the stated length is the minimum. 23.11 Sterile synthetic absorbable braided surgical suture with medium-term tissue support and complete absorption in 56–120 days; made of PGA or another biocompatible material with an equivalent profile; with biocompatible treatment to reduce friction and an atraumatic needle made of corrosion-resistant medical material. Configuration: 60.3 mm straight cutting needle; 2/0, length 70 cm. The stated needle length is nominal with a permissible deviation of ±5%; the stated suture length is the minimum; individual sterile packaging, units 252 23.12 Sterile synthetic absorbable braided surgical suture with medium-term tissue support and complete absorption in 56–120 days, with factory-applied biocompatible antimicrobial treatment. The antimicrobial intended purpose and spectrum shall be demonstrated by the Instructions for Use and Technical Documentation; no specific active substance is required. Configuration: 26 mm, 1/2 circle, taper-point needle; 4/0, length 70 cm. The stated needle length is nominal with a permissible deviation of ±5%; the stated suture length is the minimum; individual sterile packaging, units 800. The subject of the lot includes the selection of a contractor for periodically recurring supplies of sterile synthetic braided surgical suture, with medium absorption and residual strength of 25–65% on day 7 and complete absorption in 40–70 days; made of PGA or another biocompatible material with an equivalent clinical profile; with treatment to reduce friction, as follows: 24.1 26 mm, 1/2 circle, taper-point needle, 3/0; length 75 cm, units 1200 24.2 30 mm, 1/2 circle, taper-point needle, 2/0; length 75 cm, units 500 24.3 30 mm, 1/2 circle, taper-point needle, 0; length 75 cm, units 1000 24.4 36 mm, 1/2 circle, taper-point needle, 2/0; length 70 cm, units 240 24.5 36 mm, 1/2 circle, taper-point needle, 0; length 70 cm, units 240 24.6 36 mm, 1/2 circle, taper-point needle, 1; length 75 cm, units 240 24.7 40 mm, 1/2 circle, taper-point needle, 1; length 75 cm, units 240 24.8 40 mm, 1/2 circle, taper-point needle, 2; length 75 cm, units 240. For items 24.1–24.8, the stated needle length is nominal with a permissible deviation of ±5%; the stated suture length is the minimum; individual sterile packaging. The subject of the lot includes the selection of a contractor for periodically recurring supplies of sterile synthetic rapidly absorbable braided surgical suture with residual strength of 30–70% on day 7 and approximately 0% on day 14; made of PGA biocompatible material with an equivalent clinical profile; with treatment to reduce friction, as follows: 25.1 26 mm, 1/2 circle, taper-point needle; 3/0, length 75 cm, units 360 25.2 31 mm, 1/2 circle, taper-point needle; 2/0, length 90 cm, units 360 25.3 36 mm, 1/2 circle, taper-point needle; 3/0, length 75 cm, units 720 25.4 36 mm, 1/2 circle, taper-point needle; 2/0, length 75 cm, units 720 25.5 36 mm, 1/2 circle, taper-point needle; 0, length 75 cm, units 360 25.6 36 mm, 1/2 circle, taper-point needle; 1, length 90 cm, units 360 25.7 24 mm, 3/8 circle, cutting needle; 2/0, length 75 cm, units 1500 25.8 24 mm, 3/8 circle, cutting needle; 3/0, length 75 cm, units 1500. For items 25.1–25.8, the stated needle length is nominal with a permissible deviation of ±5%; the stated suture length is the minimum; individual sterile packaging. The subject of the lot includes the selection of a contractor for periodically recurring supplies of sterile soft elastic surgical tape/loops made of medical silicone or another biocompatible elastomer with equivalent flexibility and intended purpose, colour-coded for visual differentiation, as follows: 26.1 Set of 2; each tape no less than 45 cm long; nominal cross-section 1.5 × 1.0 mm, tolerance ±5%; blue; individual sterile packaging, units 120 26.2 Set of 2; each tape no less than 45 cm long; nominal cross-section 2.5 × 1.0 mm, tolerance ±5%; yellow; units 72 26.3 Set of 2; each tape no less than 45 cm long; nominal cross-section 2.5 × 1.0 mm, tolerance ±5%; white; units 120 26.4 Set of 2; each tape no less than 75 cm long; nominal cross-section 2.5 × 1.0 mm, tolerance ±5%; blue; units 72 26.5 Set of 2; each tape no less than 75 cm long; nominal cross-section 2.5 × 1.0 mm, tolerance ±5%; red; units 72. All items in individual sterile packaging. The subject of the lot includes the selection of a contractor for periodically recurring supplies of medical consumables for sterilization, as follows: 27.1 Adhesive roll for monitoring steam sterilization at t 121⁰–134⁰, units 40 27.2 Green filter paper, sheets measuring 50/50 cm, 500 sheets/package, packages 50 27.3 Packaging film compatible with steam sterilization at t 121⁰–134⁰ and formaldehyde gas sterilization, roll 27.3.1 without gusset, size 10 cm/200 m, units 100 27.3.2 without gusset, size 20 cm/200 m, units 100 27.3.3 without gusset, size 15 cm/200 m, units 100 27.3.4 without gusset, size 12.5 cm/200 m, units 100 27.3.5 without gusset, size 42 cm/200 m, units 60 27.3.6 with gusset, size 38 × 8 cm/100 m, units 60 27.4 Packaging film compatible with steam sterilization at t 121⁰–134⁰ and formaldehyde gas sterilization, pouch 27.4.1 without gusset, size 10 cm/30 cm, units 20000 27.4.2 without gusset, size 15 cm/38 cm, units 20000 27.4.3 without gusset, size 12.5 cm/30 cm, units 20000 27.4.4 without gusset, size 25 cm/40 cm, units 20000 27.5 Packaging film compatible with steam sterilization at t 121⁰–134⁰ and formaldehyde gas sterilization, roll – smooth with 3 indicators, 12.5 cm/200 m, units 30 27.6 Tablets for prolonged storage of sterile materials, units 1200 27.7 Individually packaged test sheet in a pack. Must comply with the requirements of EN ISO 17665 or a newer standard, units 300 27.8 Class 4 chemical steam indicator. Indication of a colour scale for the indicator’s colour change. Specifically intended for monitoring steam sterilization at 121–134°C. In roll form, packages 10 27.9 Class 5 chemical steam indicator. Indication of a colour scale for the indicator’s colour change. Specifically intended for monitoring steam sterilization at 121–134°C. In roll form, packages 30 27.10 Class 5 chemical steam indicator. Indication of a colour scale for the indicator’s colour change. Specifically intended for monitoring steam sterilization at 121–134°C. In booklet form, packages 30 27.11 Biological indicator for pressurised steam sterilization at 134ºC. In ampoule form. An incubator shall be offered if requested by the Contracting Authority, packages 3 27.12 Paper labels for containers with an integrated indicator for steam-vacuum sterilization. Dimensions 59 × 40 mm. To be offered in packages of no fewer than 1000 units, packages 5 27.13 Round container filters, diameter 190 mm. To be offered in packages of no fewer than 500 units, packages 2 27.14 Alkaline-enzyme cleaning agent for instruments and endoscopic equipment. Intended for treating instruments in washer-disinfectors. Based on surfactants, enzymes and complexing agents. To be offered in packaging no larger than 5 l, litres 100 27.15 Agent intended for neutralization after the cleaning stage in washer-disinfectors, as well as for acidic pre-cleaning. To be offered in packaging no larger than 5 l, litres 100 27.16 Indicator for thermal disinfection in automatic washer-disinfectors, packages 2. The subject of the lot includes the selection of a contractor for periodically recurring supplies of incise drapes for the surgical field, various sizes, as follows: 28.1 Incise drape for the surgical field, antistatic, double packaging: outer paper film, inner paper, size 15/28, units 100 28.2 Incise drape for the surgical field, antistatic, double packaging: outer paper film, inner paper, size 30/28, units 100 28.3 Incise drape for the surgical field, antistatic, double packaging: outer paper film, inner paper, size 45/28, units 100. Procedure: open. Estimated value: 799,353.85 EUR. Review the original TED notice for the complete requirement, lots, amendments and attachments.